Neogen Corporation revenue by segment NEOG

Annual Quarterly

Neogen Corporation splits its revenue 2 ways in its filings. By operating segments, the largest line in fiscal 2026, which ended May 31, 2026 was Food Safety at $641.1 million, 74% of the total. By sales mix, the largest line in fiscal 2026, which ended May 31, 2026 was Product at $768.2 million, 88% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line	FY 2027 Aug 31, 2026	FY 2026 May 31, 2026	FY 2025 May 31, 2025	FY 2024 May 31, 2024	FY 2023 May 31, 2023	FY 2022 May 31, 2022	FY 2021 May 31, 2021	FY 2020 May 31, 2020	FY 2019 May 31, 2019	FY 2018 May 31, 2018	FY 2017 May 31, 2017
Revenue	884	870	895	924	822	527	468	418	414	398	362
Operating segments
Food Safety	652 +3.4% share 73.8%	641 +0.5% share 73.7%	638 -2.6% share 71.3%	655 +19.8% share 70.9%	547 +110.3% share 66.5%	260 +11.0% share 49.3%	234 +10.1% share 50.0%	213 -0.4% share 50.9%	213 +9.8% share 51.5%	194 share 48.9%	—
Animal Safety	232 -9.5% share 26.2%	229 -10.6% share 26.3%	257 -4.6% share 28.7%	269 -2.4% share 29.1%	276 +3.2% share 33.5%	267 +14.1% share 50.7%	234 +14.0% share 50.0%	205 +2.4% share 49.1%	201 -1.3% share 48.5%	203 share 51.1%	—
Sales mix
Product	—	768 share 88.3%	—	—	715 share 86.9%	—	376 +12.1% share 80.3%	336 -1.1% share 80.2%	339 +2.5% share 82.0%	331 share 83.3%	—
Veterinary Instruments And Disposables	—	57 share 6.5%	—	66 +3.1% share 7.1%	64 share 7.8%	—	48 +12.1% share 10.3%	43 -3.7% share 10.3%	45 -6.6% share 10.8%	48 share 12.0%	—
Animal Care And Other	—	29 -15.6% share 3.4%	35 share 3.9%	—	39 -1.9% share 4.8%	40 +10.9% share 7.6%	36 +26.4% share 7.7%	28 -5.2% share 6.8%	30 -3.2% share 7.2%	31 share 7.8%	—
Rodenticides Insecticides And Disinfectants	—	18 -61.3% share 2.1%	47 share 5.3%	—	40 +11.1% share 4.8%	36 +10.8% share 6.8%	32 +11.5% share 6.9%	29 share 6.9%	—	24 share 6.0%	—
Other	—	13 -7.3% share 1.5%	14 +8.7% share 1.5%	13 share 1.4%	—	—	—	—	—	—	—
Life Sciences	—	7 +1.5% share 0.8%	6 +0.0% share 0.7%	6 +3.9% share 0.7%	6 +10.0% share 0.8%	6 -0.5% share 1.1%	6 -9.6% share 1.2%	6 -19.5% share 1.5%	8 -24.5% share 1.9%	10 share 2.6%	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Listed as: NEOG (Nasdaq)
Fiscal year ends: May 31
Incorporated in: MI
Headquarters: Lansing, MI
SEC filer status: Large accelerated filer
SEC CIK: 711377

Other In Vitro & In Vivo Diagnostic Substances companies

All 21 In Vitro & In Vivo Diagnostic Substances companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.